Skip to content

Drug interactions

Iloperidone + Rolapitant

Severity: Moderate

Iloperidone and Rolapitant: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rolapitant is a long-acting CYP2D6 inhibitor and can raise iloperidone concentrations for several weeks after a dose. Higher iloperidone exposure may add to QT prolongation, orthostatic hypotension and sedation.

What this interaction means in plain words

Iloperidone and Rolapitant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Iloperidone belongs to Central Nervous System; Rolapitant belongs to Gastrointestinal Tract.

Evidence level: Moderate

Why it happens

Rolapitant inhibits CYP2D6, reducing the metabolism of iloperidone.

What to do

Monitor for orthostasis, sedation and QTc prolongation, particularly in patients with other QT risk factors. Consider reducing the iloperidone dose if adverse effects emerge, and remember that the inhibition persists for at least 28 days.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Iloperidone and Rolapitant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Iloperidone with Rolapitant?

MediHelp rates the interaction as moderate. Iloperidone and Rolapitant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rolapitant is a long-acting CYP2D6 inhibitor and can raise iloperidone concentrations for several weeks after a dose. Higher iloperidone exposure may add to QT prolongation, orthostatic hypotension and sedation.

How serious is the interaction between Iloperidone and Rolapitant?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for orthostasis, sedation and QTc prolongation, particularly in patients with other QT risk factors. Consider reducing the iloperidone dose if adverse effects emerge, and remember that the inhibition persists for at least 28 days.

What other medicines interact with Rolapitant?

MediHelp also lists interactions of Rolapitant with, for example, Pimozide, Thioridazine, Atomoxetine. The full list is on the Rolapitant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in